1
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K/A
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) December 18, 1997
(October 3, 1997)
Commission File No. 0-11772
NU-TECH BIO-MED, INC.
(Exact name of registrant as specified in its charter)
Delaware 25-1411971
(State or other jurisdiction of (IRS Employer Identification No.)
incorporation of organization)
476 Main Street, Wakefield, Rhode Island 02879
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (401)789-9995
55 Access Road, Warwick, Rhode Island, 02886
Former name or former address, if changed since last report.)
1
2
Index to Current Report on Form 8-K
of Nu-Tech Bio-Med, Inc.
December 18, 1997
Item Page
Item 7. Financial Statements, Pro Forma Financial Information 3
and Exhibits
Signatures 4
2
3
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
On October 20, 1997, Nu-Tech Bio-Med, Inc., the Registrant, filed a
current report on Form 8-K with respect to the acquisition by the Registrant of
a 52.6% interest in Physicians Clinical Laboratory, Inc. ("PCL"), located in the
State of California. As permitted by Item 7 of Form 8-K, such Form 8-K was filed
without the required financial statements and pro forma financial information as
it was impractical to do so at that time. This current report on Form 8-K/A
provides such required financial statements, pro forma financial information and
exhibits.
a. Financial Statements of Businesses Acquired.
The required Financial Statements for ("PCL") are
attached hereto as Exhibit 99.1 (Audited Financial Statements for
the year ended February 28, 1997, together with report of
independent accountants) and Exhibit 99.2 (Unaudited Financial
Statements for the six month period ended August 31, 1997).
b. Pro Forma Financial Information.
The required pro forma financial information for the
Registrant is attached hereto as Exhibit 99.3 (Unaudited Pro
Forma Combined Balance Sheet and Unaudited Pro Forma Combined
Statements of Operation for the nine-month period ended September
30, 1997, and year ended December 31, 1996).
3
4
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
December 18, 1997 NU-TECH BIO-MED, INC.
By: /s/ J. Marvin Feigenbaum
---------------------------------
J. Marvin Feigenbaum
Chairman of the Board,
President, Chief Executive and
Chief Financial Officer
4
5
EXHIBIT INDEX
Exhibit No. Description
99.1 Audited Financial Statements for the year ended February
28, 1997, together with report of independent accountants
99.2 Unaudited Financial Statements for the six month period
ended August 31, 1997
99.3 Pro Forma Combined Balance Sheet and Statement of
Operations of Nu-Tech Bio-Med, Inc.